Document Detail


Targeting head and neck squamous cell carcinoma using a novel fusion toxin-diphtheria toxin/HN-1.
MedLine Citation:
PMID:  20814829     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The current treatment strategies, chemotherapy and radiation therapy being used for the management of cancer are deficient in targeted approach leading to treatment related toxicities and relapse. Contrarily, fusion toxins exhibit remarkable tumor specificity thus emerging as an alternative therapy for the treatment of cancer. Diphtheria toxin-HN-1 peptide (DT/HN-1) is a fusion toxin designed to target the head and neck squamous cell carcinoma (HNSCC). The aim of this study was to construct, characterize, and evaluate the cytotoxicity and specificity of DT/HN-1 fusion toxin against the HNSCC cells. The purified DT/HN-1 fusion toxin was characterized by SDS-PAGE and western blotting. Refolding of purified fusion toxins was monitored by fluorescence spectra and circular dichroism spectra. The activity of DT/HN-1 fusion toxin was demonstrated on various HNSCC cell lines by cell viability assay, cell proliferation assay, protein synthesis inhibition assay, apoptosis and cell cycle analysis. The fusion toxin DT/HN-1 demonstrated remarkably high degree of cytotoxicity specific to the HNSCC cells. The IC(50) of DT/HN-1 fusion toxin was ~1 to 5 nM in all the three HNSCC cell lines. The percentage apoptotic cells in DT/HN-1 treated UMB-SCC-745 cells are 16% compared to 4% in untreated. To further demonstrate the specific toxicity of DT/HN-1 fusion toxin towards the HNSCC cells we constructed, characterized and evaluated the efficacy of DT protein. The DT protein coding for only a fragment of diphtheria toxin without its native receptor binding domain failed to exhibit any cytotoxicity on all the cell lines used in this study thus establishing the importance of a ligand in achieving targeted toxicity. To evaluate the translocation ability of HN-1 peptide, an additional construct DTΔT/HN-1 was constructed, characterized and evaluated for its cytotoxic activity. The fusion toxin DTΔT/HN-1 deficient of the translocation domain of diphtheria toxin showed no cytotoxicity on all the cell lines clearly indicating the inability of HN-1 peptide to translocate catalytic domain of the toxin into the cytosol.
Authors:
Sirisha Potala; Rama S Verma
Related Documents :
18346899 - Ultrastructural analysis of midgut cells from culex quinquefasciatus (diptera: culicida...
8013399 - Cell proliferation not associated with carcinogenesis in rodents and humans.
4297479 - Studies on the mode of action of diphtheria toxin. vi. site of the action of toxin in l...
20047149 - Drug targeting: learning from toxin entry and trafficking in mammalian cells.
10949919 - Studies of aminochrome toxicity in a mouse derived neuronal cell line: is this toxicity...
2159009 - Generation of cell surface neoganglioproteins. gm1-neoganglioproteins are non-functiona...
12554069 - Survival of different cell lines in alginate-agarose microcapsules.
3260989 - The synthetic immunomodulator muramyl dipeptide (mdp) can stimulate activated b cells.
14972809 - Adaptations to intermittent drying in germinating eucalyptus sieberi l. johnson seeds a...
Publication Detail:
Type:  Journal Article     Date:  2010-08-01
Journal Detail:
Title:  Molecular biology reports     Volume:  38     ISSN:  1573-4978     ISO Abbreviation:  Mol. Biol. Rep.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0403234     Medline TA:  Mol Biol Rep     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1389-97     Citation Subset:  IM    
Affiliation:
Stem Cell & Molecular Biology Laboratory, Department of Biotechnology, Indian Institute of Technology Madras, #201, Bhupat and Jyoti Mehta School of Biosciences Building, Chennai, 600036, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency.
Next Document:  Study of the uncertainty in NO(2) chemiluminescence measurements due to the NO-O(3) reaction in samp...